EIP hires litigation partner from Teva

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EIP hires litigation partner from Teva

jones-m-45.jpg

UK firm EIP has hired Matthew Jones as a partner in its London office, in the latest in a string of expansive moves by the firm

M Jones

Jones (right) joins from Teva Pharmaceuticals Europe where he worked on patent litigation, including Generics [UK] v Yeda & Teva over the drug Copaxone. The Court of Appeal ruled on the case in July 2013.

Jones has worked on other patent areas in the past, including electronics and telecoms. He worked alongside EIP's head of litigation Gary Moss at both McDermott Will & Emery and Taylor Wessing.

EIP opened an office in the US in May 2013, in San Diego – the first UK IP law firm to do so. It has also said it will open an office in Düsseldorf, Germany later this year.

The firm now has 18 partners, of which five work on litigation under the EIP Legal side of the firm. The remainder are patent and trade mark attorneys.

more from across site and SHARED ros bottom lb

More from across our site

Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
The Americas research cycle has commenced, so don't miss the opportunity to submit your work
Practitioners have welcomed extended funding of the specialist police unit until 2029, while the UKIPO says it is exploring increased scale
Gift this article